N-BOC-4-Hydroxypiperidine | CAS:109384-19-2

We serve N-BOC-4-Hydroxypiperidine CAS:109384-19-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-BOC-4-Hydroxypiperidine

Chemical Name:N-BOC-4-Hydroxypiperidine
CAS.NO:109384-19-2
Synonyms:N-BOC-4-Hydroxypiperidine
1-Boc-4-piperidinol
tert-butyl 4-hydroxytetrahydropyridine-1(2H)-carboxylate
1-Boc-4-Hydroxylpiperidine
N-Boc-4-hydroxy piperidine
1-Boc-4-hydroxypiperidine
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 292.3±33.0 °C at 760 mmHg
Melting Point 61-65 °C(lit.)
Molecular Formula C10H19NO3
Molecular Weight 201.263
Flash Point 130.6±25.4 °C
 
Specification:
Appearance:White or off-white solid
Assay:≥98.0%
Other assay:≤1.0%
Moisture:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Crizotinib.



Contact us for information like N-BOC-4-Hydroxypiperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Boc-4-hydroxypiperidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Boc-4-hydroxypiperidine Use and application,1-Boc-4-hydroxypiperidine technical grade,usp/ep/jp grade.


Related News: “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.2-Amino-3-nitropyridine manufacturer “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.[4-(Trans-4-N-Propylcyclohexyl)Phenyl]Boronic Acid supplier AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.4-(Trifluoromethoxy)benzyl chloride vendor AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.Others — somewhat more cynically — wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.